YDES
YD Bio Ltd
NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY
$5.11
-1.53% today
Updated 2026-04-30
Market cap
$385.05M
P/E ratio
—
P/S ratio
754.46x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$5 – $25
Volume
0.0M
YD Bio Ltd (YDES) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |